Performance of Zhifei Biological Products declined in 2011H1, influenced by decreased Hib vaccine lot release

Date:2011-09-16hangmei  Text Size:
In 2011H1, operating revenue and net profit of Chongqing Zhifei Biological Products reached RMB312.48 million and RMB97.59 million, declined by 5.5% and 25.6% YoY respectively. The main reason for the decline was sharply reduced lot release of Hib vaccine, which occupied over 60% of the revenue. ...
Related Charts
2005-2011 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1